1. Home
  2. ANIX vs COOK Comparison

ANIX vs COOK Comparison

Compare ANIX & COOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.74

Market Cap

114.0M

Sector

Health Care

ML Signal

HOLD

Logo Traeger Inc.

COOK

Traeger Inc.

SELL

Current Price

$48.19

Market Cap

136.7M

ML Signal

SELL

Company Overview

Basic Information
Metric
ANIX
COOK
Founded
1982
1985
Country
United States
United States
Employees
N/A
433
Industry
Biotechnology: Pharmaceutical Preparations
Wholesale Distributors
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
136.7M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
ANIX
COOK
Price
$2.74
$48.19
Analyst Decision
Strong Buy
Hold
Analyst Count
3
5
Target Price
$8.67
$53.00
AVG Volume (30 Days)
365.4K
12.8K
Earning Date
05-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
$559,520,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$0.48
52 Week High
$5.46
$86.59

Technical Indicators

Market Signals
Indicator
ANIX
COOK
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
ANIX
COOK

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

Share on Social Networks: